Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06313762Completed
Randomised, open-label trial (2 arms), sponsored by IDIAPJGol. Primary endpoint: Evaluation of pain perception during the administration of two vaccines. Started Jan 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06313762.